Transcripts
Surrozen (SRZN) earnings call transcripts
Earnings call transcripts for Surrozen, Inc., with a summary, the guidance given, and what analysts pressed on.
- conference, September 16, 2026
Management framed the IND filing as a transition from Wnt platform science to clinical validation, emphasizing a dual-mechanism DME candidate and near-term funding and trial milestones.
Sep 16, 2026Positive0.62